Ann: Mesoblast Phase 3 CLBP Trial Completes Enrollment, page-208

The math on even 10% efficacy would be an outstanding number of lives saved and better than we have at present. Anxiously waiting for a much better number though in the hope that more people walk out the door instead of heading to the morgue. Seeing people saying goodbye to loved ones via a IPad is a experience no one should have to endure. We should change our product from a treatment to a vaccine and should be approved within weeks, the way I'm seeing safety and efficacy is been rolled out with them while a product that has the potential to knock this pandemic on the head as the virus is not doing the killing or loading up ICU's around the world, the main culprit is ARDS. Need to go and brushup on my skills to reduce frustration, a push bike ride is the order for the day.